摘要
目的比较静脉肾盂造影诊断中常用的显影剂复方泛影葡胺与碘海醇引起的不良反应。方法回顾性分析医院98例静脉肾盂造影患者(采用复方泛影葡胺显影剂者45例,采用碘海醇者53例)的一般资料、造影方法和不良反应。结果采用复方泛影葡胺造影的45例患者中,出现毒副反应者39例(86.67%),其中第一级副反应31例(68.89%),第二级副反应5例(11.11%),第三级副反应3例(6.67%)。采用碘海醇造影的53例患者中,出现毒副反应者有25例(47.17%),其中第一副反应22例(41.51%),第二级副反应3例(5.66%)。结论在静脉肾盂造影诊断中,应用碘海醇为显影剂的安全性优于复方泛影葡胺。
Objective To compare the side effects of compound meglumine diatrizoate and iohexol in intravenous pyelography. Methods Ninety- eight patients with intravenous pyelography in our hospital, including 45 cases of compound meglumine diatrizoate and 53 cases of iohexol, were performed the retrospective analysis on the general data, imaging method and adverse reactions. Results Among 45 cas- es of compound meglumine diatrizoate, the toxic sides effects occurred in 39 cases （86.67%）, including the first grade in 31 cases （68.89%）, second grade in 5 cases（ll. 11% ） and third grade in 3 cases（6. 67% ）. Among 53 cases of iohexol, the toxic sides effects occurred in 25 cases, including first grade in 22（41.51% ）, second grade in 3 cases （5.66%） and no third grade. Conclusion In intravenous pyelography, the safety using iohexol as developer is superior to that using compound meglumine diatrizoate.
出处
《中国药业》
CAS
2012年第7期60-61,共2页
China Pharmaceuticals
关键词
复方泛影葡胺
碘海醇
毒副反应
compound meglumine diatrizoate
iohexol
toxic side effects
